| abstract |
The invention relates to the use of a Cav3 channel blocking agent, in particular ethosuximide, in the treatment of pain triggered by excess nociception. The invention also relates to the use of such an agent in the treatment of dysfunctional pain with an inflammatory component or in the treatment of dysfunctional pain with a non-inflammatory component, as well as the use of this agent during a treatment. anti-inflammatory, independently or simultaneously. |